Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives

Contraception

Volumn 64, Issue 3, 2001, Pages 145-148

  De Leo, Vincenzo ^a   la Marca, Antonio ^a   Morgante, Giuseppe ^a   Lucani, Barbara ^a   Nami, Renato ^a   Ciotta, Liliana ^b   Cianci, Antonio ^b   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Aldosterone; Blood pressure; Oral contraceptive; Renin

Indexed keywords

ALDOSTERONE; ARIANNA; ETHINYLESTRADIOL PLUS GESTODENE; FEDRA; LOW DOSE ORAL CONTRACEPTIVE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; DRUG TOLERABILITY; DRUG USE; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; ORAL CONTRACEPTION; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

ADULT; ALDOSTERONE; BLOOD PRESSURE; BODY WEIGHT; CONTRACEPTIVES, ORAL; DRUG EVALUATION; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPERTENSION; NORPREGNENES; RENIN;

EID: 0034767592     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(01)00237-2     Document Type: Article

References (24)

1. When the pill causes a rise in blood pressure
2. Estrogens and hypertension: Effect of discontinuing estrogens on blood pressure, exchangeable sodium and the renini-aldosterone system
3. Hypertension in women
4. Malignant hypertension in women aged 15 to 44 years and its relation to cigarette smoking and oral contraceptives
5. Malignant hypertension in women of childbearing age and its relation to contraceptive pill
6. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons
7. Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate
8. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestagen
9. Blood pressure and contraceptive use
10. Cardiovascular risk status and oral contraceptive use: United States 1976-1980
11. Oral contraceptives and hypertension
12. Effect of four oral contraceptives on blood pressure in the pill-free interval
13. The treatment of hypertension in women
14. Effects of ethinylestradiol on the renin-angiotensin-aldosterone system and on transcortin in women and men
15. Effects of a new oral contraceptive containing an antimineralcorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance and lipid metabolism
16. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives
17. Effect of progesterone on renal sodium handling in man: Relation to aldosterone excretion and plasma renin activity
18. Natural progesterone and antihypertensive action
19. Plasma angiotensin II and aldosterone during the menstrual cycle
20. Plasma renin activity and aldosterone excretion during prolonged progesterone administration
21. Dihydrospirorenone - A new progestogen with antimineralcorticoid activity: Effects on ovulation, electrolyte excretion and the renin-aldosterone system in normal women
22. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays
23. New progestins - Clinical experiences: Gestodene
24. Gestodene, an innovative progestogen